TRXADE GROUP, INC. Contracts & Agreements
87 Contracts & Agreements
- Business Finance (41 contracts)
- Business Operations (6)
- Human Resources (25)
- Intellectual Property (1)
- Mergers & Acquisitions (2)
- Uncategorized (12)
- Supplier Agreement (Filed With SEC on October 13, 2023)
- Asset Purchase Agreement, dated August 21, 2023, by and among Superlatus Inc., Perfect Day, Inc., and The Urgent Company, Inc (Filed With SEC on August 24, 2023)
- Form of MEDS Shareholder Registration Rights Agreement for MEDS Rights (Filed With SEC on July 31, 2023)
- Form of Lock-Up Agreement (Filed With SEC on July 31, 2023)
- Amended and Restated Agreement and Plan of Merger, dated July 14, 2023 by and between TRxADE Health, Inc. and Superlatus, Inc (Filed With SEC on July 14, 2023)
- Stock Swap Agreement dated June 28, 2023, by and among TRxADE Health, Inc., Suren Ajjarapu and Prashant Patel (Filed With SEC on June 30, 2023)
- Agreement and Plan of Merger dated as of June 30, 2023, by and among TRxADE Health, Inc., Foods Merger Sub, Inc., and Superlatus Inc (Filed With SEC on June 30, 2023)
- Amendment to Acquisition Letter, dated June 23, 2023 by and between TRxADE Health, Inc. and Superlatus, Inc (Filed With SEC on June 23, 2023)
- Binding Letter of Intent, dated June 22, 2023 by and between TRxADE Health, Inc. and Superlatus, Inc (Filed With SEC on June 23, 2023)
- Agreement for the Purchase and Sale of Future Receipts dated September 14, 2022, by and between TRxADE HEALTH, INC. and Agile Capital Funding LLC and Guaranty of Performance dated... (Filed With SEC on May 15, 2023)
- Description of Registered Securities (Filed With SEC on March 27, 2023)
- Voluntary Withdrawal and Release Agreement effective February 4, 2023, by and between TRxADE HEALTH, INC., SOSRx, LLC and Exchange Health, LLC (Filed With SEC on February 7, 2023)
- Membership Interest Purchase Agreement dated January 20, 2023, by and among Community Specialty Pharmacy, LLC, Wood Sage, LLC, as buyer, and TRxADE HEALTH, Inc., as seller (Filed With SEC on January 23, 2023)
- Membership Interest Purchase Agreement dated January 20, 2023, by and among Alliance Pharma Solutions, LLC, Wood Sage, LLC, as buyer, and TRxADE HEALTH, Inc., as seller (Filed With SEC on January 23, 2023)
- Second Amendment to Offer Letter between TRxADE HEALTH, Inc. and Janet Huffman dated January 17, 2023 and effective September 1, 2022 (Filed With SEC on January 20, 2023)
- Third Amendment to Employment Agreement between TRxADE HEALTH, Inc. and Suren Ajjarapu dated January 17, 2023 and effective September 1, 2022 (Filed With SEC on January 20, 2023)
- Second Amendment to Employment Agreement between Trxade, Inc. and Prashant Patel dated January 17, 2023 and effective September 1, 2022 (Filed With SEC on January 20, 2023)
- Trxade Group, Inc. 2019 Equity Incentive Plan Notice of Restricted Stock Grant and Restricted Stock Grant Agreement (CFO Grant December 2022) (Filed With SEC on December 16, 2022)
- Agreement for the Purchase and Sale of Future Receipts dated September 14, 2022, by and between TRxADE HEALTH, INC. and Agile Capital Funding LLC and Guaranty of Performance dated... (Filed With SEC on November 7, 2022)
- Form of Securities Purchase Agreement dated October 4, 2022, by and between TRxADE HEALTH, INC. and the Purchaser (Filed With SEC on October 7, 2022)
- Form of Common Stock Purchase Warrant (Filed With SEC on October 7, 2022)
- Form of Pre-Funded Common Stock Purchase Warrant (Filed With SEC on October 7, 2022)
- Placement Agency Agreement dated October 4, 2022, between TRxADE HEALTH, INC. and Maxim Group LLC (Filed With SEC on October 7, 2022)
- Second Amendment to Common Stock Purchase Agreement, dated September 12, 2022, by and between TRxADE HEALTH, Inc. and White Lion Capital LLC (Filed With SEC on September 13, 2022)
- First Amendment to Common Stock Purchase Agreement, dated September 12, 2022, by and between TRxADE HEALTH, Inc. and White Lion Capital LLC (Filed With SEC on September 13, 2022)
- Common Stock Purchase Agreement, dated September 7, 2022, by and between TRxADE HEALTH, Inc. and White Lion Capital LLC (Filed With SEC on September 13, 2022)
- Form of Restricted Stock Grant Agreement Trxade Group, Inc Amended and Restated 2019 Equity Incentive Plan (August 2022 Board Grants) (Filed With SEC on September 1, 2022)
- Form of Restricted Stock Grant Agreement Trxade Group, Inc. Amended and Restated 2019 Equity Incentive Plan (August 2022 Employee and Officer Grants) (Filed With SEC on September 1, 2022)
- Amendment to Offer Letter with Ms. Huffman (Filed With SEC on September 1, 2022)
- First Amendment to Employment Agreement with Mr. Patel (Filed With SEC on September 1, 2022)
- Second Amendment to Employment Agreement with Mr. Ajjarapu (Filed With SEC on September 1, 2022)
- Agreement for the Purchase and Sale of Future Receipts dated June 27, 2022, by and between TRxADE HEALTH, INC. and Agile Capital Funding LLC and Guaranty of Performance dated June... (Filed With SEC on July 25, 2022)
- Offer Letter dated February 3, 2022, between Trxade, Inc. and Janet Huffman (Filed With SEC on April 1, 2022)
- Form of Non-Competition and Confidentiality Agreement (Trxade, Inc.) (Filed With SEC on April 1, 2022)
- Form of Mutual Nondisclosure Agreement (Trxade, Inc.) (Filed With SEC on April 1, 2022)
- Description of Registered Securities (Filed With SEC on March 28, 2022)
- Guaranty dated March 1, 2022, by TRxADE HEALTH, INC. in favor of McKesson Corporation (Filed With SEC on March 11, 2022)
- Masters Drug Company, Inc. and its Affiliated Companies Terms and Conditions dated March 1, 2022, provided by Integra Pharma Solutions, LLC (Filed With SEC on March 4, 2022)
- Guaranty dated March 1, 2022, by TRxADE HEALTH, INC. in favor of McKesson Corporation (Filed With SEC on March 4, 2022)
- Distribution Services Agreement dated February 15, 2022, by and between SOSRx LLC and Integra Pharma Solutions LLC (Filed With SEC on February 16, 2022)
- Non Recourse Promissory Note in the amount of $500,000, dated February 15, 2022, by TRxADE HEALTH, INC. in favor of Exchange Health, LLC (Filed With SEC on February 16, 2022)
- Member Asset Contribution Agreement dated February 15, 2022, between Exchange Health, LLC and SOSRx LLC (Filed With SEC on February 16, 2022)
- Equity Distribution Agreement, dated August 6, 2021 between the Company and EF Hutton, division of Benchmark Investments LLC (Filed With SEC on August 6, 2021)
- Trxade Group, Inc. Second Amended and Restated 2019 Equity Incentive Plan (Filed With SEC on May 28, 2021)
- Trxade Group, Inc. 2019 Equity Incentive Plan Stock Option Agreement (Filed With SEC on April 26, 2021)
- Trxade Group, Inc. 2019 Equity Incentive Plan Restricted Stock Grant Agreement (Filed With SEC on April 26, 2021)
- Form of First Amendment to Trxade Group, Inc. 2019 Equity Incentive Plan Restricted Stock Grant Agreement (April 2020 Grants to Employees; Independent Directors 2020 Award, 2020... (Filed With SEC on August 4, 2020)
- Trxade Group, Inc. Independent Director Compensation Policy adopted April 14, 2020 (Filed With SEC on July 27, 2020)
- Executive Employment Agreement dated effective June 19, 2020, entered into by and between Trxade Group, Inc. and Howard A. Doss (Filed With SEC on June 26, 2020)
- Trxade Group, Inc. Amended and Restated 2019 Equity Incentive Plan (Filed With SEC on June 1, 2020)
- Restricted Stock Grant Agreement (Mr. Ajjarapu 2020 Performance Bonus)(Updated) May 5, 2020 (Filed With SEC on May 7, 2020)
- First Amendment to Executive Employment Agreement with Suren Ajjarapu dated May 5, 2020 (Filed With SEC on May 7, 2020)
- April 14, 2020 Executive Employment Agreement with Suren Ajjarapu (Filed With SEC on April 16, 2020)
- Form of Restricted Stock Grant Agreement (Independent Directors 2020 Award, 2020 CFO Award and 2020 Legal Counsel) April 14, 2020 (Filed With SEC on April 16, 2020)
- Form of Stock Option Agreement (April 2020 Grants to Employees) April 14, 2020 (Filed With SEC on April 16, 2020)
- Restricted Stock Grant Agreement (Mr. Ajjarapu 2020 Performance Bonus) April 14, 2020 (Filed With SEC on April 16, 2020)
- Description of Registered Securities (Filed With SEC on March 30, 2020)
- Underwriting Agreement dated February 13, 2020, by and between Trxade Group, Inc. and Dawson James Securities, Inc. as the representative of the underwriters named therein (Filed With SEC on February 13, 2020)
- Form of Underwriting Agreement (Filed With SEC on February 12, 2020)
- Form of Underwriting Agreement (Filed With SEC on January 27, 2020)
- Asset Purchase Agreement dated October 23, 2019 between Trxade Group, Inc.s wholly-owned subsidiary Bonum Health, LLC, a Delaware limited liability company, Bonum Health, LLC, a... (Filed With SEC on October 28, 2019)
- Securities Purchase Agreement dated October 23, 2019, by and among Trxade Group, Inc. and Bonum Health, LLC, a Florida limited liability company (Filed With SEC on October 28, 2019)
- Form of Registration Rights Agreement dated October 23, 2019, by and among Trxade Group, Inc. and Bonum Health, LLC, a Florida limited liability company (Filed With SEC on October 28, 2019)
- Transition Services Agreement dated October 23, 2019, by and among Trxade Group, Inc. and Bonum Health, LLC, a Florida limited liability company (Filed With SEC on October 28, 2019)
- Trxade Group, Inc. 2019 Equity Incentive Plan (Filed With SEC on October 15, 2019)
- Form of Securities Purchase Agreement (Filed With SEC on October 2, 2019)
- Form of Securities Purchase Agreement (Filed With SEC on July 31, 2019)
- Form of Securities Purchase Agreement (Filed With SEC on July 19, 2019)
- Form of Securities Purchase Agreement (Filed With SEC on July 11, 2019)
- Indemnification Agreement (Filed With SEC on March 22, 2019)
- TRXADE GROUP, INC. SECURITIES PURCHASE AGREEMENT (Filed With SEC on November 14, 2018)
- PROMISSORY NOTE (Filed With SEC on July 5, 2017)
- PROMISSORY NOTE (Filed With SEC on July 5, 2017)
- TRXADE GROUP, INC. INVESTMENT WARRANT AGREEMENT (Filed With SEC on January 5, 2017)
- ______________________________________________________________________________ PURCHASE AND SALE AGREEMENT by and among Gajan A. Mahendiran and Amudha Mahendiran, as Buyer, and... (Filed With SEC on January 5, 2017)
- EXHIBIT 10.1 INDEMNIFICATION AGREEMENT (Filed With SEC on August 25, 2016)
- EXHIBIT 10.1 AMENDMENT TO CONVERTIBLE PROMISSORY NOTE PURCHASE AGREEMENT AND NOTE WESTMINSTER PHARMACEUTICAL, LLC (Filed With SEC on June 3, 2016)
- EXHIBIT 10.14 AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT TRXADE GROUP, INC. (Filed With SEC on March 28, 2016)
- WESTMINSTER PHARMACEUTICALS, LLC CONVERTIBLE PROMISSORY NOTE PURCHASE AGREEMENT (Filed With SEC on October 27, 2015)
- CONVERTIBLE PROMISSORY NOTE (Filed With SEC on October 27, 2015)
- TRXADE GROUP, INC. INVESTMENT WARRANT AGREEMENT (Filed With SEC on October 27, 2015)
- INDEMNIFICATION AGREEMENT (Filed With SEC on March 18, 2015)
- INDEMNIFICATION AGREEMENT (Filed With SEC on December 23, 2014)
- TRXADE GROUP, INC. INVESTMENT WARRANT AGREEMENT (Filed With SEC on September 26, 2014)
- TRXADE GROUP, Inc. SUBSCRIPTION AGREEMENT Restricted Common Stock at $1.50 per Share (Filed With SEC on September 26, 2014)
- TRXADE GROUP, INC. COMMON STOCK REGISTRATION RIGHTS AGREEMENT (Filed With SEC on September 26, 2014)
- LICENSE AGREEMENT (Filed With SEC on May 1, 2009)
